Medicover AB (FRA:5M0B) Debt-to-Equity : 2.11 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medicover AB Debt-to-Equity?

Medicover AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €246 Mil. Medicover AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €828 Mil. Medicover AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €508 Mil. Medicover AB's debt to equity for the quarter that ended in Mar. 2024 was 2.11.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medicover AB's Debt-to-Equity or its related term are showing as below:

FRA:5M0B' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14 Med: 1.19 Max: 2.27
Current: 2.11

During the past 10 years, the highest Debt-to-Equity Ratio of Medicover AB was 2.27. The lowest was 0.14. And the median was 1.19.

FRA:5M0B's Debt-to-Equity is ranked worse than
88.67% of 547 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs FRA:5M0B: 2.11

Medicover AB Debt-to-Equity Historical Data

The historical data trend for Medicover AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicover AB Debt-to-Equity Chart

Medicover AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.42

0.82

1.48

1.99

2.02

Medicover AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															1.95	1.99	2.10	2.02	2.11

Competitive Comparison of Medicover AB's Debt-to-Equity

For the Medical Care Facilities subindustry, Medicover AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicover AB's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medicover AB's Debt-to-Equity falls into.

Medicover AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medicover AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(229.1	+	774.6)	/	496.5
	=	2.02

Medicover AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(245.6	+	828.2)	/	508.2
	=	2.11

Medicover AB (FRA:5M0B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medicover AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medicover AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicover AB (FRA:5M0B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicover AB (FRA:5M0B) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

MCVEF:USA MCOV B:Sweden

Address

Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, SE-102 46

Website

https://www.medicover.com

Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.

Medicover AB (FRA:5M0B) Headlines

No Headlines